Would a higher threshold make this simpler for you to administer, so that IRS could focus its resources more efficiently, and therefore would you support congressional efforts to increase the threshold?

I would like to see the new energy credits from the IRA work in support of American manufacturing, spurring genuine domestic supply chains, particularly in the solar industry where so much capacity needs to be built quickly.

I know Senator Hassan--you know, we have talked about this. Senator Hassan and I are working on this, to increase the threshold to $10,000, cutting down red tape for taxpayers and providing the advantages to IRS that you mentioned.

Things are getting better. My constituents are still frustrated with the IRS--no surprise--particularly small businesses waiting to receive the Employee Retention Tax credit.

But they are dropping out.

I have been working on this my whole career, pushing for Medicare price negotiations, pushing to crack down on drug company price-gouging.

I called the administration last year to finalize its DIR fee reform proposal to help lower drug costs for seniors.

One of the biggest problems with our whole prescription drug system--and I think all five of you know this--is how opaque it is.

I think they do it intentionally wrong.

With the Inflation Reduction Act, we stood up to big pharma and dark money and finally began to take action to bring down the cost of prescription drugs.

One of the biggest problems with our whole prescription drug system--and I think all five of you know this--is how opaque it is.

But they are dropping out.

Another concern I have with DIR fees is that pharmacies are paid or forced to pay based on quality measures.

With the Inflation Reduction Act, we stood up to big pharma and dark money and finally began to take action to bring down the cost of prescription drugs.

Another concern I have with DIR fees is that pharmacies are paid or forced to pay based on quality measures.

I think they do it intentionally wrong.

I have been working on this my whole career, pushing for Medicare price negotiations, pushing to crack down on drug company price-gouging.

I called the administration last year to finalize its DIR fee reform proposal to help lower drug costs for seniors.

But PBMs think that they can pay below cost to pharmacies and still get away with it.

I called the administration last year to finalize its DIR fee reform proposal to help lower drug costs for seniors.

I think they do it intentionally wrong.

Another concern I have with DIR fees is that pharmacies are paid or forced to pay based on quality measures.

I have been working on this my whole career, pushing for Medicare price negotiations, pushing to crack down on drug company price-gouging.

With the Inflation Reduction Act, we stood up to big pharma and dark money and finally began to take action to bring down the cost of prescription drugs.

The scene of the crime does not start with the regulators before us. Instead, we must look inside the bank, at the bank CEOs, and at the Trump-era banking regulators, who made it their mission, again, to give Wall Street everything it…